A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Generalized Anxiety Disorder

In brief

A clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder. This study will be accepting both male and female subjects between the ages of 18 years and 65 years old. The study will be held in Approximately 50 global study centers and approximately 15 additional centers for a separate Japan population. Participation in the study can be up to approximately 12 weeks.

Key facts

Study ID
NCT05729373
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
434
Starts
2023-03-08
Expected to finish
2025-09-26
Last updated by the study team
2025-10-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.